期刊
WOUND REPAIR AND REGENERATION
卷 29, 期 4, 页码 573-581出版社
WILEY
DOI: 10.1111/wrr.12954
关键词
chronic wounds; extracellular matrix; fibroblast-to-myofibroblast differentiation; M2 phenotype macrophage; myofibroblast
Diabetes is a systemic disease that affects the body's ability to regulate blood sugar levels, leading to complications such as chronic non-healing wounds, which can significantly impact patients' quality of life. Scientific studies have shown that high glucose levels can interfere with fibroblast differentiation and myofibroblast function, affecting extracellular matrix production and wound contraction. Further research on potential treatments targeting these pathways is essential for improving wound healing in diabetic patients.
Diabetes is a systemic disease in which the body cannot regulate the amount of sugar, namely glucose, in the blood. High glucose toxicity has been implicated in the dysfunction of diabetic wound healing, following insufficient production (Type 1) or inadequate usage (Type 2) of insulin. Chronic non-healing diabetic wounds are one of the major complications of both types of diabetes, which are serious concerns for public health and can impact the life quality of patients significantly. In general, diabetic wounds are characterized by deficient chemokine production, an unusual inflammatory response, lack of angiogenesis and epithelialization, and dysfunction of fibroblasts. Increasing scientific evidence from available experimental studies on animal and cell models strongly associates impaired wound healing in diabetes with dysregulated fibroblast differentiation to myofibroblasts, interrupted myofibroblast activity, and inadequate extracellular matrix production. Myofibroblasts play an important role in tissue repair by producing and organizing extracellular matrix and subsequently promoting wound contraction. Based on these studies, hyperglycaemic conditions can interfere with cytokine signalling pathways (such as growth factor-beta pathway) affecting fibroblast differentiation, alter fibroblast apoptosis, dysregulate dermal lipolysis, and enhance hypoxia damage, thus leading to damaged microenvironment for myofibroblast formation, inappropriate extracellular matrix modulation, and weakened wound contraction. In this review, we will focus on the current available studies on the impact of diabetes on fibroblast differentiation and myofibroblast function, as well as potential treatments related to the affected pathways.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据